[특허]Alternative operation mode for an implantable medical device based upon lead condition

Cyberonics, Inc.

검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
검색연산자

검색도움말
검색연산자	기능	검색시 예
()	우선순위가 가장 높은 연산자	예1) (나노 (기계 \| machine))
공백	두 개의 검색어(식)을 모두 포함하고 있는 문서 검색	예1) (나노 기계) 예2) 나노 장영실
\|	두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색	예1) (줄기세포 \| 면역) 예2) 줄기세포 \| 장영실
!	NOT 이후에 있는 검색어가 포함된 문서는 제외	예1) (황금 !백금) 예2) !image
*	검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색	예) semi*
""	따옴표 내의 구문과 완전히 일치하는 문서만 검색	예) "Transform and Quantization"

과학기술 지식인프라 ScienceON

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

특허 상세정보

MyON담기

내보내기 페이스북 공유 트위터 공유 카카오톡 공유

Alternative operation mode for an implantable medical device based upon lead condition

특허상세정보
국가/구분	United States(US) Patent 등록
국제특허분류(IPC7판)	A61N-001/32 A61N-001/05 A61N-001/36 A61N-001/08
미국특허분류(USC)	607/002; 607/008; 607/009; 607/027; 607/045; 607/118
출원번호	US-0925746 (2007-10-26)
등록번호	US-8942798 (2015-01-27)
발명자 / 주소	Armstrong, Randolph K. Rodriguez, Albert A. Maschino, Steven E.
출원인 / 주소	Cyberonics, Inc.
대리인 / 주소	Cyberonics, Inc.
인용정보	피인용 횟수 : 2 인용 특허 : 192

초록
▼

A method, apparatus, and system for determining an adverse operational condition associated with a lead assembly in an implantable medical device used for providing a therapeutic electrical signal to a cranial nerve. A first impedance associated with the lead assembly configured to provide the therapeutic electrical signal to a cranial nerve is detected. A determination is made as to whether the first impedance is outside a first predetermined range. A second impedance is detected. The detection of the second impedance is performed within a predetermined period of time from the time of the detection of the first impedance. A determination is made as to whether the second impedance is outside a second predetermined range. If the first impedance is outside the first range and the second impedance is outside the second range, the implantable medical device is prevented from providing the therapeutic electrical signal.

대표
청구항
▼

1. A method comprising: determining first impedance associated with a lead assembly of an implantable medical device;determining whether the first impedance is within an acceptable range;determining at least one parameter associated with the lead assembly when the first impedance is out of the acceptable range;analyzing the at least one parameter to determine whether a lead assembly problem is intermittent;performing a pre-stimulation check prior to delivery of a therapeutic electrical signal when the lead assembly problem is intermittent;delivering the therapeutic electrical signal when the pre-stimulation check indicates that the lead assembly is functional; anddelaying delivery of the therapeutic electrical signal when the pre-stimulation check indicates that the lead assembly is not functional. 2. The method of claim 1, wherein determining the first impedance comprises: providing a controlled current signal through a first terminal and a second terminal associated with the lead assembly;measuring a voltage across the first and second terminals during at least a portion of a time period during which the controlled current signal is provided through the first and second terminals to determine a measured voltage; anddetermining the first impedance based upon the controlled current signal and the measured voltage. 3. The method of claim 2, wherein the controlled current signal is a test pulse that has a small magnitude compared to the therapeutic electrical signal. 4. The method of claim 2, wherein an impedance value of a first lead is subtracted from an impedance determined from the controlled current signal and the measured voltage to generate the first impedance. 5. The method of claim 1, further comprising preventing the implantable medical device from providing the therapeutic electrical signal when the lead assembly problem is determined to be a significant problem. 6. The method of claim 1, wherein the implantable medical device enters a secondary mode from a normal mode of operation when the lead assembly problem is determined to exist. 7. The method of claim 6, wherein, when the implantable medical device is in the secondary mode, the method further comprises: shutting down an operation of the implantable medical device;altering a dosage of the therapeutic electrical signal;disabling an electrode associated with the lead assembly;or combinations thereof. 8. The method of claim 7, wherein altering the dosage comprises reducing a number of pulses in the therapeutic electrical signal, increasing a time period of off time, reducing current amplitude of the therapeutic electrical signal, reducing a frequency of a pulse train of the therapeutic electrical signal, decreasing a pulse width of the therapeutic electrical signal, or combinations thereof. 9. The method of claim 1, further comprising performing a notification process when the lead assembly problem is determined to exist. 10. The method of claim 9, wherein the notification process comprises performing a patient notification process, a health-care professional notification process, a manufacturer notification process, or combinations thereof. 11. The method of claim 9, wherein the notification process comprises providing an audible notification, a tactile notification, a vibration notification, an electrical notification, an electronic notification, or combinations thereof. 12. A method comprising: determining via a controller of an implantable medical device whether an impedance associated with a lead assembly of the implantable medical device is within an accepted range;performing at least one test to generate data associated with the lead assembly when the impedance is not within the accepted range;classifying a type of problem associated with the lead assembly based on the data;performing a first remedial action when the type of the problem is an intermittent problem, wherein the first remedial action includes: performing a pre-stimulation check prior to delivery of a therapeutic electrical signal;delivering the therapeutic electrical signal when the pre-stimulation check indicates that the lead assembly is functional; anddelaying delivery of the therapeutic electrical signal when the pre-stimulation check indicates that the lead assembly is not functional; andperforming a second remedial action when the type of the problem is a second type, wherein the first remedial action is different than the second remedial action. 13. The method of claim 12, wherein classifying the type of the problem comprises determining whether the problem is the intermittent problem, a severe problem, a significant problem, or combinations thereof. 14. The method of claim 12, wherein the second remedial action comprises stopping application of therapeutic electrical signals by the implantable medical device, modifying at least one electrical parameter of the therapeutic electrical signals provided by the implantable medical device, running a pre-stimulation diagnostic check prior to delivering the therapeutic electrical signal, disabling an electrode associated with the lead assembly, or combinations thereof. 15. The method of claim 12, wherein the at least one test comprises a current output test, a lead impedance test, a power output test, an energy output test, a charge imbalance test, a compensation voltage test, or combinations thereof. 16. A method comprising: monitoring a lead condition of a lead assembly of an implantable medical device configured to provide therapeutic electrical signals;receiving data that indicates a lead condition problem;performing a lead condition analysis to classify a type of the lead condition problem;preventing the implantable medical device from providing the therapeutic electrical signals when the type of the lead condition problem is a severe problem; andimplementing a secondary operation mode of the implantable medical device when the type of the lead condition problem is other than the severe problem by: performing a pre-stimulation check regimen prior to providing a therapeutic electrical signal of the therapeutic electrical signals when the type is an intermittent problem; andimplementing one of an alternate dosage of the therapeutic electrical signals applied by the implantable medical device or a change in an electrode configuration when the type is neither the intermittent problem nor the severe problem. 17. The method of claim 16, further comprising providing a notification to a patient, a health-care professional, a manufacturer of at least a portion of the implantable medical device, a manufacturer of at least a portion of the lead assembly in response to detecting the lead condition problem, or combinations thereof. 18. The method of claim 16, wherein the lead condition analysis comprises: detecting a lead impedance;determining whether the lead impedance is outside a predetermined range;performing a diagnostic function in response to a determination that the lead impedance is outside the predetermined range to generate diagnostic data; andperforming a statistical analysis of the diagnostic data. 19. The method of claim 16, wherein the implantable medical device is configured to provide cranial nerve stimulation. 20. The method of claim 16, wherein the alternate dosage comprises a reduction in a number of pulses, an increase in a period of off time, a reduction in current amplitude, a reduction in a frequency of a pulse train of the therapeutic electrical signal of the therapeutic electrical signals, a decrease in pulse width, or combinations thereof. 21. A non-transitory computer readable medium comprising instructions, that when executed by a processor, cause the processor to perform operations including: performing at least one test to generate data associated with a lead assembly of an implantable medical device when an impedance associated with the lead assembly is outside of an accepted range;detecting that a problem is associated with the lead assembly based on the at least one test;classifying a type of the problem associated with the lead assembly;implementing a first remedial action when the type of the problem is a first type by: performing a pre-stimulation check before initiation of a therapeutic electrical signal from the implantable medical device to a patient when the type of the problem is an intermittent problem;initiating the therapeutic electrical signal when the pre-stimulation check indicates that there is no lead assembly problem; anddelaying the therapeutic electrical signal when the pre-stimulation check indicates existence of the lead assembly problem; andimplementing a second remedial action when the type of the problem is a second type, wherein the first remedial action is different than the second remedial action. 22. The non-transitory computer readable medium of claim 21, wherein the at least one test comprises a current output test, a lead impedance test, a power output test, an energy output test, a charge imbalance test, a compensation voltage test, or combinations thereof. 23. The non-transitory computer readable medium of claim 21, wherein operations further include, in response to detecting the problem, providing a notification to the patient, a health-care professional, a manufacturer of at least a portion of the implantable device, a manufacturer of at least a portion of the lead assembly, or combinations thereof. 24. The non-transitory computer readable medium of claim 21, wherein the operations implementing the first remedial action include preventing application of the therapeutic electrical signal from the implantable medical device to the patient when the type of the problem is a severe problem.

이 특허에 인용된 특허 (192)

이 특허를 인용한 특허 피인용횟수: 2

IPC 상위 출원인

내보내기

상세정보
내보내기 구분	파일저장 인쇄 메일전송
구성항목	관리번호, 국가코드, 자료구분, 상태, 출원번호, 출원일자, 공개번호, 공개일자, 등록번호, 등록일자, 발명명칭(한글), 발명명칭(영문), 출원인(한글), 출원인(영문), 출원인코드, 대표IPC 관리번호, 국가코드, 자료구분, 상태, 출원번호, 출원일자, 공개번호, 공개일자, 공고번호, 공고일자, 등록번호, 등록일자, 발명명칭(한글), 발명명칭(영문), 출원인(한글), 출원인(영문), 출원인코드, 대표출원인, 출원인국적, 출원인주소, 발명자, 발명자E, 발명자코드, 발명자주소, 발명자 우편번호, 발명자국적, 대표IPC, IPC코드, 요약, 미국특허분류, 대리인주소, 대리인코드, 대리인(한글), 대리인(영문), 국제공개일자, 국제공개번호, 국제출원일자, 국제출원번호, 우선권, 우선권주장일, 우선권국가, 우선권출원번호, 원출원일자, 원출원번호, 지정국, Citing Patents, Cited Patents
저장형식	Text(ASCII format) Excel format PIAS분석(.xls)
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	> 총 건의 자료가 검색되었습니다. > 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) > 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. > 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) > 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오 > ~ > Text(ASCII format) Excel format

과학기술 지식인프라 ScienceON

ScienceON Chatbot

연합인증

특허 상세정보

Alternative operation mode for an implantable medical device based upon lead condition

초록
▼

대표
청구항
▼

이 특허에 인용된 특허 (192)

이 특허를 인용한 특허 피인용횟수: 2

IPC 상위 출원인

과제정보

상세정보조회

원문조회

IPC 상세정보(version : 201201)

연구과제 성과물(0)

참여연구원의 다른 문헌(0)

처리중입니다.

잠시만 기다려주세요.

ScienceON Chatbot

연합인증

특허 상세정보

Alternative operation mode for an implantable medical device based upon lead condition

초록 ▼

대표청구항 ▼

이 특허에 인용된 특허 (192)

이 특허를 인용한 특허 피인용횟수: 2

IPC 상위 출원인

과제정보

상세정보조회

원문조회

IPC 상세정보(version : 201201)

연구과제 성과물(0)

참여연구원의 다른 문헌(0)

처리중입니다.

잠시만 기다려주세요.

초록
▼

대표
청구항
▼